Zobrazeno 1 - 10
of 118
pro vyhledávání: '"Pierre, Czernichow"'
Autor:
Pierre Czernichow
Publikováno v:
Les Tribunes de la santé. :79-90
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8717d747b46c129b78aad1be65321281
https://doi.org/10.3917/seve1.074.0079
https://doi.org/10.3917/seve1.074.0079
Are patients living far from hospital at higher risk of late adjuvant chemotherapy for colon cancer?
Autor:
Thomas Vermeulin, Hana Lahbib, Mélodie Lucas, Pierre Czernichow, Florence Jusot, Frédéric Di Fiore, Véronique Merle
Publikováno v:
British Journal of Clinical Pharmacology. 88:3903-3910
Late adjuvant chemotherapy (aCT) administration after colectomy (56 d) is known to be associated with impaired prognosis. We aim to identify risk factors associated with late aCT, especially the travel time between patients' home and hospital.We perf
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2a087de3bd33e72f6aaea198c7001c05
https://doi.org/10.1111/bcp.15300
https://doi.org/10.1111/bcp.15300
Autor:
Isabelle Gillet, Robert Moulias, Eric Andro, Frédérique Rubatat, Claude Lepresle, Yvette Cloix, Dominique Riché, Bernard Crozat, Pierre Czernichow
Publikováno v:
Santé Publique. 33:997-1003
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ae96cb7b1c595cb51c4a50ff4dab36b4
https://doi.org/10.3917/spub.216.0997
https://doi.org/10.3917/spub.216.0997
Autor:
Herve Daubert, Marion Lottin, Frédéric Di Fiore, Christian Gray, Thomas Vermeulin, Pierre Czernichow, Mélodie Lucas, Véronique Merle, Hélène Marini, Agnès Loeb, Florian Guisier, Pierre Michel, Rémy De Mil, David Sefrioui
Publikováno v:
Bulletin du Cancer
Bulletin du Cancer, John Libbey Eurotext, 2018, 105 (11), pp.1003-1011. ⟨10.1016/j.bulcan.2018.09.005⟩
Bulletin du Cancer, John Libbey Eurotext, 2018, 105 (11), pp.1003-1011. ⟨10.1016/j.bulcan.2018.09.005⟩
Summary Introduction During the last decade, most studies on totally implanted venous access-associated adverse events (TIVA-AE) were conducted retrospectively and/or were based on a limited sample size. The aim of our survey was two-fold: to estimat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bbd55ce31fb2197a7438340b332b342e
https://doi.org/10.1016/j.bulcan.2018.09.005
https://doi.org/10.1016/j.bulcan.2018.09.005
Autor:
L. Froment, Hana Lahbib, Véronique Merle, F. Di Fiore, F. Jusot, Mélodie Lucas, V. Josset, Thomas Vermeulin, Pierre Czernichow, Guy Launoy
Publikováno v:
Oncologie. 20:85-91
Objectif : Notre objectif etait de construire, a partir du Programme de medicalisation des systemes d’information (PMSI), un indicateur de suivi des delais d’initiation de la chimiotherapie (CT) adjuvante pour cancer du colon et de l’evaluer. M
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::27ce6e69b3d766850d22cfd56e67abaf
https://doi.org/10.3166/onco-2018-0014
https://doi.org/10.3166/onco-2018-0014
Autor:
Pierre Michel, Mélodie Lucas, Josselin Diot, Véronique Merle, Caroline Brifault, Emmanuel Huet, Frédéric Di Fiore, Pierre Czernichow, Marion Lottin, Thomas Vermeulin, Hana Lahbib
Publikováno v:
Bulletin du Cancer
Bulletin du Cancer, John Libbey Eurotext, 2019, 106, pp.959-968. ⟨10.1016/j.bulcan.2019.09.004⟩
Bulletin du Cancer, John Libbey Eurotext, 2019, 106, pp.959-968. ⟨10.1016/j.bulcan.2019.09.004⟩
Summary Introduction Totally implanted venous access (TIVA) improves the safety and welfare of patients treated with cancer chemotherapy (CCT). We aimed to evaluate patients’ perception of TIVA placement, TIVA use, and information on TIVA, and to a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a312da56f36619fa114a6778b5158144
https://pubmed.ncbi.nlm.nih.gov/31623835
https://pubmed.ncbi.nlm.nih.gov/31623835
Autor:
Nathalie Contentin, Hélène Marini, Véronique Merle, Pierre Michel, Luc Thiberville, Jean-François Muir, Frédéric Di Fiore, Agnès Loeb, Emmanuel Huet, Christian Gray, Akpéné Fred, Christian Pfister, Pierre Czernichow, Marion Lottin, Christophe Peillon
Publikováno v:
Supportive Care in Cancer
Supportive Care in Cancer, Springer Verlag (Germany), 2016, 24 (4), pp.1857-1863. ⟨10.1007/s00520-015-2969-1⟩
Supportive Care in Cancer, Springer Verlag (Germany), 2016, 24 (4), pp.1857-1863. ⟨10.1007/s00520-015-2969-1⟩
International audience; PURPOSE:Although considered safer than central venous catheters for administration of cancer chemotherapy, totally implanted venous access (TIVA) is associated with adverse events that may impair prognosis and quality of life
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9a48f0c6d2da14517c3b1fc62a6305e7
https://hal-normandie-univ.archives-ouvertes.fr/hal-02379449
https://hal-normandie-univ.archives-ouvertes.fr/hal-02379449
Autor:
Caroline Weill Giès, Hélène Grandjean, Pierre Czernichow, Jean-Michel Lutz, Laurent Madec, Zeina Mansour, Bruno Maresca, François Martin, Marie Préau, Lionel Vincent, Véronique Mallet, Ann Pariente-Khayat, François Mouterde, Elise Proult, Caroline Massot, Justine Bettinger, Anne Duburcq, Valérie Donio Laurène Courouve
Publikováno v:
HAL
National audience; Le Haut Conseil de la santé publique (HCSP) présente son rapport d’évaluation de 10 ans de politique de lutte contre le cancer (2004-2014).À partir de l’analyse des six axes clés de la politique de lutte contre le cancer (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::5e035821acfedeb83dbf4e02b28870ff
https://hal.ehesp.fr/hal-01824917
https://hal.ehesp.fr/hal-01824917
Autor:
Sophie Stamenkovic, Anne Solesse, Laura Zanetti, Pascale Zagury, Muriel Vray, Pascal Auquier, Elisabeth Baumelou, Frédéric de Bels, Marie-Christine Bene, Alain Bernard, Jean-Pierre Boissel, Marie-Odile Carrere, Pierre Czernichow, Benoit Dervaux, Eveline Eschwege, Pascale Fabbro-Peray, Bruno Falissard, Annie Fourrier, Didier Guillemot, François Lacoin, Maryse Lapeyre-Mestre, Patrick Maison, Jacques Massol, Emmanuel Oger, Françoise Roudot-Thoraval, Patrice Trouiller, Mahmoud Zureik
Publikováno v:
Therapies. 67:409-421
The assessment of a health technology is frequently accompanied by uncertainty about its impact, at short or long terms, on the health of the population. The Health Authorities may request additional « post-registration » data that will allow a rel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ecd7c7d4dcdf5ea22ea12aa035d748f4
https://doi.org/10.2515/therapie/2012065
https://doi.org/10.2515/therapie/2012065
Autor:
Véronique Merle, V. Josset, Christine Lebaron, Pierre Czernichow, O. Langlois, Hélène Marini, François Proust, Noelle Frebourg, Marie Gilles Baray, Stéphane Derrey
Publikováno v:
BMJ Quality & Safety. 21:432-438
Background Unplanned return to the operating theatre (UROT) is a useful trigger tool that could be used to identify surgical adverse events (SAEs). The present study describes the feasibility of SAE surveillance in neurosurgical patients, based on UR
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c2fa093d802b6489e5499f4d17ee7acc
https://doi.org/10.1136/bmjqs-2011-000355
https://doi.org/10.1136/bmjqs-2011-000355